Ladder Bio
PrivateLast Round
Seed
Nov 12, 2025
Total Funding Raised
$5.5M
Momentum Score
75 /100
Company Overview
Ladder Bio is a biotechnology company developing a novel therapeutic modality, Spiroligomer™ molecules, for targeted drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ladder Bio Comps
Public and private peers based on sector, stage, and business model.
Ladder Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 12, 2025 |
Ladder Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Medical Excellence Capital | Seed |
| Hatch Biofund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2025
$5.5M raised in Seed round.
Ladder Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ladder Bio's valuation, stock price, and market status.
